| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.549.600 | 1.241.548 | - | - | - | - | - | - | - | - |
| Total Income - EUR | 1.557.544 | 1.244.048 | - | - | - | - | - | - | - | - |
| Total Expenses - EUR | 1.518.760 | 1.235.851 | - | - | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | 38.784 | 8.197 | - | - | - | - | - | - | - | - |
| Net Profit/Loss - EUR | 28.118 | 4.599 | - | - | - | - | - | - | - | - |
| Employees | 25 | 19 | - | - | - | - | - | - | - | - |
Check the financial reports for the company - Libra Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 38.962 | 29.254 | - | - | - | - | - | - | - | - |
| Current Assets | 706.903 | 513.762 | - | - | - | - | - | - | - | - |
| Inventories | 159.459 | 172.885 | - | - | - | - | - | - | - | - |
| Receivables | 542.896 | 310.005 | - | - | - | - | - | - | - | - |
| Cash | 4.548 | 30.872 | - | - | - | - | - | - | - | - |
| Shareholders Funds | 103.169 | 37.420 | - | - | - | - | - | - | - | - |
| Social Capital | 45 | 45 | - | - | - | - | - | - | - | - |
| Debts | 642.697 | 505.595 | - | - | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | - | - | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Libra Pharm Srl